AI in Drug Development
AI in Drug Development Is Changing the Field Conversation: Are MSLs and Sales Teams Ready?
Much of the current discussion around AI and field readiness has focused on tactical applications, such as AI-simulated HCP conversations for upskilling. Less attention has been paid to how AI-driven drug development reshapes the scientific narrative for field teams and the questions they will face as a result.
When Timelines Change
Planning for the Unexpected: Training for Launch When Timelines Change
Product launches in life sciences are built on months and even years of careful planning, with training tightly aligned to anticipated FDA approvals. But approval timelines don’t always land where expected.
Accordion Title
Lorem ipsum dolor sit amet malesuada
Lorem ipsum dolor sit amet consectetur. Turpis cursus scelerisque quam at elit eget id pulvinar neque. Convallis pretium.